-Down to Earth Pharma company's strategy of different prices for different countries to affect quality treatment of 185 million people infected with Hepatitis C worldwide Health activists and agencies on Tuesday criticised leading pharmaceutical company Bristol-Myers Squibb (BMS)'s commercial strategy to sell new Hepatitis C medicine Daclatasvir, stating it would exclude a large number of patients who cannot afford expensive treatment. BMS had announced that it would create a tiered pricing strategy for...
More »SEARCH RESULT
Total Matching Records found : 561
Letter to PM about US-India Bilateral Relations on Intellectual Property
-Kafila.org Dear Prime Minister Modi ji, We, the undersigned, wish to share with you some of our concerns on India's position on intellectual property (IP), particularly in the context of bilateral relations between the United States of America and India. We gather from the US-India Joint Statement dated 30 September 2014 that the Indian Government (a)greeing on the need to foster innovation in a manner that promotes economic growth...
More »Drug stocks at health centres run by government to be digitized -Lohit Jagwani
-Livemint The health ministry will also digitize various govt-run health centres including primary health centres, community health centres and hospitals New Delhi: The Union health ministry is rolling out an online database of medicines stocked at government-run health centres and a centralized agency to procure drugs as patient groups and civil society organizations highlight shortages triggering greater drug immunity and higher treatment costs. The ministry will also digitize various government-run health centres...
More »Pvt sector deserts war on TB, funding down 33% since 2011 -Subodh Varma
-The Times of India Even as tuberculosis (TB) continues to haunt the world, a new study has revealed that funding for research and development of new drugs to fight the disease is floundering. Private sector funding has declined by more than a third since 2011 as pharma companies are closing their TB research programmes. Pfizer shut down its TB drug discovery programme in 2012, AstraZeneca in 2013 and Novartis in 2014. Meanwhile,...
More »Stolen generation -Rekha Dixit
-The Week Shambhu Kumar, 8, quite liked his job as a domestic help in a small town in Assam. He had to mind two children nearly his age, keep an eye on the ducks and be available for chores all day. It wasn't too hard, and he was well fed, too, though he missed his grandmother, a tea garden labourer. One day, some women from the state education department came to the...
More »
